Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
donald trump
3
×
fda
3
×
indiana blog main
indiana top stories
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
scott gottlieb
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
approval
car-t
celgene
clinical study
democrats
drug prices
loxo oncology
novartis
2025
What
afternoon
airport
allogene
annual
anticipated
apocalypse
awaited
beds
bio
blueprint
cancer
celgene
cost
crispr
cut
days
details
diversity
drug
drugs
fallout
gone
home
hot
house
immunotherapy
investors
ipo
j.p
jpm
juno
long
lower
meant
million
nearly
new
notes
plan
pledges
Language
Current search:
fda
×
" donald trump "
×
medicare
×
" new york top stories "
×
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details